Noctura 400

We are pleased to let you know we have partnered with PolyPhotonix Medical – manufacturer of Noctura 400, the non-invasive treatment for Diabetic Retinopathy and Diabetic Macular Oedema.

Clarity Pharma is the Exclusive Prescription Sales Agent for all Healthcare Professional (Prescription Only) orders. For any Prescription Orders new or repeat please contact us directly.

Supply and Service

Our Exclusive Prescription Sales Agent agreement is a “Supply and Service” agreement, to understand more, please see our Prescription Process below:

  1. Noctura 400 is prescribed on an FP10 or ETP and received by a pharmacy / dispenser
  2. The patient must confirm/provide their contact details with the pharmacy / dispenser
  3. Clarity Pharma will receive a copy of the FP10 or ETP and the patient’s telephone number from the pharmacy / dispenser
  4. Clarity will pass on the information as an instruction to supply to PolyPhotonix Medical (Noctura 400 manufacturer)*.
  5. PolyPhotonix Medical (Noctura 400 manufacturer) will contact the patient directly to set up the device and the provide support
  6. PolyPhotonix Medical (Noctura 400 manufacturer) sends the device directly to the patient and delivery confirmation to Clarity Pharma
  7. Clarity Pharma will forward delivery confirmation to the Pharmacies, GPs, Dispensaries, Clinics or Hospitals, who can then confirm the item as dispensed on their systems and claim reimbursement
    * Please note: GDPR codes of practice are followed at all times by Clarity Pharma and PolyPhotonix Medical (Noctura 400 manufacturer).
Supply and Service

About Noctura 400

Noctura 400 is a CE marked, MHRA registered medical device.

It has been evaluated within the NHS and has proven safety and efficacy for the prevention and treatment of diabetic retinopathy and diabetic macular oedema in adults.

Low-level light is used to reduce the retina’s oxygen demand during sleep and prevent hypoxia.

Noctura 400 is non invasive, does not disturb sleep and can be used on its own or as an adjunct to current treatments.

 

For more information please visit the Noctura 400 website.

About Noctura 400